Note Receivable - Maat Pharma SA (PAR:MAAT) - Alpha Spread
M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.3 EUR 2.24% Market Closed
Market Cap: 101.4m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Maat Pharma SA
Note Receivable Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Note Receivable Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Note Receivable
€222k
CAGR 3-Years
17%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nanobiotix SA
PAR:NANO
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innate Pharma SA
PAR:IPH
Note Receivable
€14.6m
CAGR 3-Years
-25%
CAGR 5-Years
178%
CAGR 10-Years
N/A
Genfit SA
NASDAQ:GNFT
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Maat Pharma SA's Note Receivable?
Note Receivable
222k EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Note Receivable amounts to 222k EUR.

What is Maat Pharma SA's Note Receivable growth rate?
Note Receivable CAGR 5Y
30%

Over the last year, the Note Receivable growth was 63%. The average annual Note Receivable growth rates for Maat Pharma SA have been 17% over the past three years , 30% over the past five years .

Back to Top